12:31 EST Catalyst Pharmaceuticals (CPRX) reports settlement of Firdapse patent litigation with Teva (TEVA)
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPRX:
- Catalyst Pharmaceuticals trading halted, news pending
- Catalyst Pharmaceuticals management to meet with Truist
- Biotech Alert: Searches spiking for these stocks today
- Catalyst Pharmaceuticals initiated with an Overweight at Stephens
- Catalyst Pharmaceuticals price target raised to $36 from $30 at Truist